Skip to main content
OpenTrials

Clinical trial condition

Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma

Explore clinical trials studying Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma trial results

Recruiting

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

NCT05886036

Conditions
Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Springs Coral Springs, Florida, United States
View all 37 locations
View Trial Details

Related conditions